Kevin M D'Auria

Title: Kevin M D'Auria: Innovator in Noninvasive Prenatal Screening

Introduction

Kevin M D'Auria is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of prenatal screening, particularly through his innovative methods that enhance the accuracy of detecting chromosomal abnormalities in fetuses.

Latest Patents

Kevin M D'Auria holds a patent for "Noninvasive prenatal screening using dynamic iterative depth optimization with depth-scaled variance determination." This patent addresses the analysis of fetal and maternal cell-free DNA to determine chromosomal abnormalities such as aneuploidy or microdeletions. The methods described involve measuring the dosage of a test chromosome and determining statistical significance based on depth-scaled variation values.

Career Highlights

Kevin is currently associated with Myriad Women's Health, Inc., where he applies his expertise in genetic testing and prenatal diagnostics. His work has been instrumental in advancing noninvasive techniques that provide critical information to expectant parents.

Collaborations

Throughout his career, Kevin has collaborated with esteemed colleagues, including Dale E Muzzey and Kevin R Haas. These partnerships have fostered innovation and contributed to the development of cutting-edge technologies in the field of women's health.

Conclusion

Kevin M D'Auria's contributions to noninvasive prenatal screening exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements that improve prenatal diagnostics and support expectant families.